Finance

Lists
Why is ANTHEM down 2,66%?
Dive Deeper
ANTHEM:NSE
Anthem Biosciences Limited
847,00 INR
-2,66%
(-23,15) 1D
14 ოქტ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ANTHEM...
Open
865,00 INR
High
868,60 INR
Low
845,05 INR
Mkt. cap
477,51 მლრ.
Avg. vol.
793,08 ათ.
Volume
545,12 ათ.
Dividend
0,24%
Quarterly dividend
0,50 INR
Ex-dividend date
25 ივნ. 2026
P/E ratio
83,24
52-wk high
977,55 INR
52-wk low
579,15 INR
EPS
10,18 INR
No. of employees
2 ათ.
Open
865,00 INR
High
868,60 INR
Low
845,05 INR
Mkt. cap
477,51 მლრ.
Avg. vol.
793,08 ათ.
Volume
545,12 ათ.
Dividend
0,24%
Quarterly dividend
0,50 INR
Ex-dividend date
25 ივნ. 2026
P/E ratio
83,24
52-wk high
977,55 INR
52-wk low
579,15 INR
EPS
10,18 INR
No. of employees
2 ათ.
News stories
From web sources and news partners
About Anthem Biosciences Limited
CEO-
Employees2,28 ათ.
Founded2006
Headquarters-
SectorHealth care
Last report
22 ივლ. 2026
Fiscal period
Q1 2027
2,11 INR / 1,80 INR
+17,22%beat
Revenue / Est. (INR)
4,18 მლრდ. / 4,43 მლრდ.
-5,60%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
5,50 მლრდ.
4,23 მლრდ.
6,16 მლრდ.
4,18 მლრდ.
Cost of goods sold
2,23 მლრდ.
1,43 მლრდ.
2,57 მლრდ.
1,46 მლრდ.
Cost of revenue
2,23 მლრდ.
1,43 მლრდ.
2,57 მლრდ.
1,46 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
677,16 მლნ.
704,79 მლნ.
745,64 მლნ.
788,36 მლნ.
Operating expense
1,42 მლრდ.
1,58 მლრდ.
1,22 მლრდ.
1,51 მლრდ.
Total operating expenses
3,66 მლრდ.
3,00 მლრდ.
3,80 მლრდ.
2,98 მლრდ.
Operating income
1,84 მლრდ.
1,23 მლრდ.
2,36 მლრდ.
1,21 მლრდ.
Other non operating income
482,29 მლნ.
335,30 მლნ.
-1,05 მლრდ.
248,87 მლნ.
EBT including unusual items
2,30 მლრდ.
1,30 მლრდ.
2,78 მლრდ.
1,45 მლრდ.
EBT excluding unusual items
2,30 მლრდ.
1,56 მლრდ.
2,67 მლრდ.
1,45 მლრდ.
Income tax expense
561,74 მლნ.
376,57 მლნ.
881,59 მლნ.
246,40 მლნ.
Effective tax rate
24,47%
28,86%
31,72%
17,04%
Other operating expenses
410,47 მლნ.
528,85 მლნ.
79,01 მლნ.
426,16 მლნ.
Net income
1,73 მლრდ.
928,17 მლნ.
1,90 მლრდ.
1,20 მლრდ.
Net profit margin
31,53%
21,93%
30,81%
28,68%
Earnings per share
-
1,96
-
2,11
Interest and investment income
-
-
792,70 მლნ.
-
Interest expense
-30,31 მლნ.
-3,52 მლნ.
-15,47 მლნ.
-8,87 მლნ.
Net interest expenses
-30,31 მლნ.
-3,52 მლნ.
777,23 მლნ.
-8,87 მლნ.
Depreciation and amortization charges
334,99 მლნ.
345,33 მლნ.
395,91 მლნ.
299,87 მლნ.
EBITDA
2,14 მლრდ.
1,45 მლრდ.
2,69 მლრდ.
1,54 მლრდ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები